AI, specifically in the form of multi-omics, is anticipated to have a significant impact across various sectors and industries. This technology is expected to revolutionize areas like drug discovery, despite the challenges faced by certain sectors like biotech. Companies like Recursion, utilizing AI for drug discovery, are seen as having a competitive edge due to the superior results it delivers, highlighting the transformative power of AI in various fields.
In this episode, Peter and Cathie dive into investing in exponential companies, Bitcoin's role as a new asset class within a global monetary system, the potential of artificial general intelligence (AGI), and the convergence of technologies like AI, robotics, and biotechnology.
- 20:13 | The Trillion-Dollar Transformation of Travel
- 40:30 | The AI Revolution: Is Capital Overwhelming?
- 58:20 | Bitcoin: The New Financial Frontier
Cathie Wood is the founder of the $60 billion Investment Management firm, ARK Invest, a key figure in the investment landscape for disruptive innovations such as self-driving cars and genomics.
Learn more about ARK Invest: https://ark-invest.com/
Cathie’s podcasts: https://ark-invest.com/podcasts/
Investing with $500 : https://ark-ventures.com/videos/an-introduction-to-the-titan-app/
Join my executive summit, Abundance360: https://www.abundance360.com/summit
____________
I only endorse products and services I personally use. To see what they are, please support this podcast by checking out our sponsors:
Get started with Fountain Life and become the CEO of your health: https://fountainlife.com/peter/
Use my code PETER25 for 25% off your first month's supply of Seed's DS-01® Daily Synbiotic: seed.com/moonshots
_____________
Get my new Longevity Practices 2024 book: https://bit.ly/48Hv1j6
I send weekly emails with the latest insights and trends on today’s and tomorrow’s exponential technologies. Stay ahead of the curve, and sign up now: Tech Blog
_____________
Connect With Peter:
Twitter
Instagram
Youtube
Moonshots